ACTU vs UNH · $49.0M cap vs P/E 30, rev $112.03B
Actuate Therapeutics, Inc. Common stock (ACTU) versus UnitedHealth Group Incorporated (UNH) — a side-by-side from cached financials, not a winner call.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
UnitedHealth Group Incorporated (UNH) is a healthcare plans company listed on NYSE. It is led by Stephen J. Hemsley.
ACTU does not have a complete income-statement cache yet.
Latest reported UNH revenue for 2026-06-30 was $112.03B. Net income was $5.48B. Revenue was up 0.3% from 2026-03-31 to 2026-06-30. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
ACTU currently screens at market cap $49.0M. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
Not investment advice. Open the ACTU and UNH stock pages for the full models.
Not investment advice.